Welcome to the resource library, where you can find strategy, research and examples of promising practice in medicine, commissioning and drug services for hepatitis C
Resources
Showing 81 to 90 of 299 resources
-
Working Together to Reduce Harm (Substance Misuse) Delivery Plan 2016 - 2018
This Welsh Government delivery plan describes the work that will be undertaken reduce the harm caused by substance misuse. It includes actions related to hepatitis C such as the implementation of routine opt-out testing in substance misuse services.UK, Wales Sep 2016 Strategy & Planning PDF -
Hepatitis C Coalition: Report on Operational Delivery Network Visits
This report, published by the Hepatitis C Coalition, provides an overview of visits undertaken by the Coalition to Operational Delivery Networks (ODNs) across England. It sets out the detailed analysis of findings from meetings with a variety of health professionals across the country, and includes a number of recommendations intended to further improve the effectivesness of the ODNs.England Sep 2016 Reports & Research PDF -
Together for Health: Liver Disease Annual Report 2016 - Setting the Baseline
This report, published by the Welsh Government and NHS Wales, provides an overview of liver disease in Wales, and gives details of the actions currently underway to tackle liver disease, including hepatitis C.UK, Wales Reports & Research PDF -
Penrose Inquiry Recommendation: Report of a Scottish Government Commissioned Short Life Working Group
In light of the Penrose Inquiry recommendation, the Scottish Government recommended that a Short-Life Working Group, involving key stakeholders including those from the Scottish Government and the Scottish National Blood Transfusion Service, be established by Health Protection Scotland. This is the group's final report, which includes a number of key recommendations, including the delivery of a national awareness campaign.Scotland Sep 2016 Reports & Research PDF -
Liver Disease in the South West: A health needs assessment
This document provides epidemiological data and an overview of primary and secondary care services for general liver disease in the South West of England and also assesses the main preventable causes, which includes hepatitis C.UK, England, South West Aug 2016 Reports & Research PDF -
Laboratory reports of hepatitis C: 2016
This report from Public Health England provides statistics on the number of hepatitis A and hepatitis C laboratory reports in England and Wales from January - March 2016.England, Wales Aug 2016 Reports & Research PDF -
Hepatitis C in the UK 2016 report
This report, published by Public Health England, summarises the scale of the hepatitis C issue in the UK in 2015, in order to help support focused action in UK countries via their national action plans, and in order to eliminate hepatitis C as a major public health threat by 2030. It provides a host of relevant statistics and information related to prevalence, diagnosis, testing and treatment.UK Aug 2016 Reports & Research PDF -
Extrahepatic manifestations of chronic hepatitis C infection
This research article provides an overview of the extrahepatic (i.e. non-liver) impact of hepatitis C, which include cardiovascular, renal, metabolic and central nervous system diseases.UK, Rest of World Aug 2016 Reports & Research PDF -
Hepatitis C among drug users in Europe: Epidemiology, treatment and prevention
This report, produced by the European Monitoring Centre for Drugs and Drug Addiction, provides an overview of the epidemiology of hepatitis C in Europe. It contains chapters on issues such as providing hepatitis C treatment to people who inject drugs, strategies to improve hepatitis C care and increasing uptake of treatment among people who inject drugs, and hepatitis C prevention among people who inject drugs.UK, Rest of World Aug 2016 Reports & Research, Strategy & Planning PDF -
HCV Action good practice case study: Outreach service in Newcastle
This HCV Action good practice case study looks at an outreach service that has been developed in Newcastle. Based at Freeman Hospital, Newcastle, the service delivers three outreach centres in locations across the north east region. Prior to the outreach service, hospital attendance at new hepatitis C patient appointments was less than 50%. The service has resulted in attendance rates of 75%, an increase in the numbers of people being treated, and comparable Sustainable Virological Response (SVR) rates as hospital-based treatment.North East, UK, England Jul 2016 Case study PDF